Abbott Signs Licensing Agreement With ALZpath, A Provider Of Blood-Based Diagnostics For Alzheimer's, For Its Proprietary Phosphorylated Tau 217 Antibody

뉴스 본문을 불러오고 있어요.

Abbott Signs Licensing Agreement With ALZpath, A Provider Of Blood-Based Diagnostics For Alzheimer's, For Its Proprietary Phosphorylated Tau 217 Antibody | 웨이프 WAPE

Abbott Signs Licensing Agreement With ALZpath, A Provider Of Blood-Based Diagnostics For Alzheimer's, For Its Proprietary Phosphorylated Tau 217 Antibody

기사 요약

관련 종목

댓글 —